Kenvue (KVUE) Jumps 17% on Strong Earnings, Kimberly-Clark $48.7-Billion Merger

We recently published 10 Stocks Soaring Past Expectations. Kenvue Inc. (NYSE:KVUE) is one of the big names that led last week’s charge.

Kenvue grew its share prices by 17.47 percent week-on-week, as investors loaded portfolios following twin news that it achieved a strong earnings performance in the past quarter of the year, alongside plans to merge with Kimberly-Clark for $48.7 billion.

In a joint statement earlier in the week, Kenvue Inc. (NYSE:KVUE) said it agreed to merge with Kimberly-Clark, under which the latter would acquire each KVUE share for $3.50 cash and 0.14625 of Kimberly-Clark shares, for a total consideration of $21.01 based on the latter’s closing price as of October 31, 2025.

The transaction is expected to combine several well-known brands under one roof, including Tylenol, Aveeno, Huggies, Kotex, Listerine, Neutrogena, Band-Aid, among others.

Copyright: stocking / 123RF Stock Photo

Meanwhile, Kenvue Inc. (NYSE:KVUE) also announced the results of its earnings performance in the third quarter of the year, during which it incurred a 4 percent jump in net income of $398 million, higher than the $383 million in the same period last year.

Net sales, however, were lower by 3.46 percent to $3.764 billion from $3.899 billion year-on-year.

For the full-year 2025, Kenvue Inc. (NYSE:KVUE) expects both net sales and organic sales to drop by low single digits, assuming approximately neutral impact from foreign currency translation.

Adjusted diluted earnings per share are expected to be in the range of $1.00 to $1.05.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.